Clinical Trial Update: A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) [Phase 3]

View source ↗

Summary

Phase 3 SINGLE trial comparing dolutegravir/abacavir/lamivudine once daily to Atripla (efavirenz/emtricitabine/tenofovir) in HIV-1 infection; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• Epzicom (abacavir/lamivudine)
• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I | Phase 3 | Status: COMPLETED | Results posted: 2014-07-02